ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Text of PDQ Statement on Breast Screening

September 17, 1993

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975